Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Queensland Health
Cantor Fitzgerald
Argus Health
Colorcon
Cerilliant
Deloitte
Accenture
Moodys

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020699

« Back to Dashboard

NDA 020699 describes EFFEXOR XR, which is a drug marketed by Wyeth Pharms Inc and is included in one NDA. It is available from seventeen suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the EFFEXOR XR profile page.

The generic ingredient in EFFEXOR XR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

Summary for 020699

Tradename:1
Applicant:1
Ingredient:1
Patents:3
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 020699

Suppliers and Packaging for NDA: 020699

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0833 0008-0833-03 100 BLISTER PACK in 1 CARTON (0008-0833-03) > 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0008-0833-02)
EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0833 0008-0833-22 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0833-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrengthEQ 37.5MG BASE
Approval Date:Oct 20, 1997TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Sep 20, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 20, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 20, 2017Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 020699

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-003Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-001Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-002Oct 20, 1997► Subscribe► Subscribe
Wyeth Pharms IncEFFEXOR XRvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020699-004Oct 20, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
Cerilliant
Cantor Fitzgerald
Harvard Business School
Merck
McKinsey
US Department of Justice
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot